- Home
- SAGE vs LVRO Comparison
SAGE vs LVRO Comparison
Compare SAGE & LVRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- LVRO
- Stock Information
- Founded
- SAGE 2010
- LVRO 2017
- Country
- SAGE United States
- LVRO Brazil
- Employees
- SAGE N/A
- LVRO N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- LVRO Blank Checks
- Sector
- SAGE Health Care
- LVRO Finance
- Exchange
- SAGE Nasdaq
- LVRO Nasdaq
- Market Cap
- SAGE 462.2M
- LVRO 387.1M
- IPO Year
- SAGE 2014
- LVRO N/A
- Fundamental
- Price
- SAGE $6.94
- LVRO $3.25
- Analyst Decision
- SAGE Hold
- LVRO Strong Buy
- Analyst Count
- SAGE 20
- LVRO 3
- Target Price
- SAGE $11.39
- LVRO $6.83
- AVG Volume (30 Days)
- SAGE 2.8M
- LVRO 14.3K
- Earning Date
- SAGE 02-12-2025
- LVRO 03-06-2025
- Dividend Yield
- SAGE N/A
- LVRO N/A
- EPS Growth
- SAGE N/A
- LVRO N/A
- EPS
- SAGE N/A
- LVRO N/A
- Revenue
- SAGE $106,399,000.00
- LVRO $1,691,812,087.00
- Revenue This Year
- SAGE N/A
- LVRO N/A
- Revenue Next Year
- SAGE $122.32
- LVRO $12.53
- P/E Ratio
- SAGE N/A
- LVRO N/A
- Revenue Growth
- SAGE 837.60
- LVRO 0.48
- 52 Week Low
- SAGE $4.62
- LVRO $3.06
- 52 Week High
- SAGE $27.68
- LVRO $8.33
- Technical
- Relative Strength Index (RSI)
- SAGE 60.28
- LVRO 27.62
- Support Level
- SAGE $6.75
- LVRO $3.06
- Resistance Level
- SAGE $7.88
- LVRO $3.97
- Average True Range (ATR)
- SAGE 0.38
- LVRO 0.44
- MACD
- SAGE 0.13
- LVRO -0.16
- Stochastic Oscillator
- SAGE 64.39
- LVRO 7.48
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About LVRO Lavoro Limited
Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.